Bio-Techne Tops Q2 Earnings & Revenue Estimates, Stock Up in Premarket

Bio-Techne (TECH) reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of 42 cents, which exceeded the Zacks Consensus Estimate by 10.5%. The bottom line improved from the year-ago figure of 40 cents.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.The quarter's adjustments eliminated the impact of certain one-time items, including amortization of intangibles, amortization of Wilson Wolf intangible assets and acquired inventory and restructuring and restructuring-relat ...